Evidence map›Paper›PMID 26528278›Full record

ArticleFrontiers in microbiology2015

Characterization of CTX-M-14-producing Escherichia coli from food-producing animals.

Xiao-Ping Liao, Jing Xia, Lei Yang, Liang Li, Jian Sun, Ya-Hong Liu, Hong-Xia Jiang

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. High prevalence ofApplied and environmental microbiology · 2025
    Article
  5. Interplay between bacterial clones and plasmids in the spread ofOne health (Amsterdam, Netherlands) · 2025
    Article
  6. Article
  7. Plasmid-mediated acquisition and chromosomal integration ofAntimicrobial agents and chemotherapy · 2024
    Article
  8. Article
  9. Extended Spectrum β-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Emergence and Spread of Cephalosporinases in Wildlife: A Review.Animals : an open access journal from MDPI · 2021
    Review
  17. Antimicrobial Resistance Genes in ESBL-ProducingAntibiotics (Basel, Switzerland) · 2021
    Article
  18. Article
  19. Emergence of Multidrug-ResistantFrontiers in cellular and infection microbiology · 2021
    Article
  20. Characterization of Carbapenem-ResistantInfection and drug resistance · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiao-Ping LiaoLaboratory of Veterinary Pharmacology, College of Veterinary Medicine, South China Agricultural University Guangzhou, China.
Jing XiaLaboratory of Veterinary Pharmacology, College of Veterinary Medicine, South China Agricultural University Guangzhou, China.
Lei YangLaboratory of Veterinary Pharmacology, College of Veterinary Medicine, South China Agricultural University Guangzhou, China.
Liang LiLaboratory of Veterinary Pharmacology, College of Veterinary Medicine, South China Agricultural University Guangzhou, China.
Jian SunLaboratory of Veterinary Pharmacology, College of Veterinary Medicine, South China Agricultural University Guangzhou, China.
Ya-Hong LiuLaboratory of Veterinary Pharmacology, College of Veterinary Medicine, South China Agricultural University Guangzhou, China ; Jiangsu Co-Innovation Centre for Prevention and Control of Important Animal Infectious Diseases and Zoonoses Yangzhou, China.
Hong-Xia JiangLaboratory of Veterinary Pharmacology, College of Veterinary Medicine, South China Agricultural University Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial resistance to the third-generation cephalosporin antibiotics has become a major concern for public health. This study was aimed to determine the characteristics and distribution of bla CTX-M-14, which encodes an extended-spectrum β-lactamase, in Escherichia coli isolated from Guangdong Province, China. A total of 979 E. coli isolates isolated from healthy or diseased food-producing animals including swine and avian were examined for bla CTX-M-14 and then the bla CTX-M-14 -positive isolates were detected by other resistance determinants [extended-spectrum β-lactamase genes, plasmid-mediated quinolone resistance, rmtB, and floR] and analyzed by phylogenetic grouping analysis, PCR-based plasmid replicon typing, multilocus sequence typing, and plasmid analysis. The genetic environments of bla CTX-M-14 were also determined by PCR. The results showed that fourteen CTX-M-14-producing E. coli were identified, belonging to groups A (7/14), B1 (4/14), and D (3/14). The most predominant resistance gene was bla TEM (n = 8), followed by floR (n = 7), oqxA (n = 3), aac(6')-1b-cr (n = 2), and rmtB (n = 1). Plasmids carrying bla CTX-M-14 were classified to IncK, IncHI2, IncHI1, IncN, IncFIB, IncF or IncI1, ranged from about 30 to 200 kb, and with insertion sequence of ISEcp1, IS26, or ORF513 located upstream and IS903 downstream of bla CTX-M-14. The result of multilocus sequence typing showed that 14 isolates had 11 STs, and the 11 STs belonged to five groups. Many of the identified sequence types are reported to be common in E. coli isolates associated with extraintestinal infections in humans, suggesting possible transmission of bla CTX-M-14 between animals and humans. The difference in the flanking sequences of bla CTX-M-14 between the 2009 isolates and the early ones suggests that the resistance gene context continues to evolve in E. coli of food producing animals.

Indexed as

cephalosporinCTX-M-14Escherichia coliMLSTplasmids

Identifiers

PMID26528278
PMCPMC4606122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.